Humanwell Healthcare (Group) Co.,Ltd. (SHA:600079)
China flag China · Delayed Price · Currency is CNY
19.28
+0.05 (0.26%)
At close: Feb 6, 2026

SHA:600079 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
24,12625,38624,44522,27620,51020,598
Other Revenue
49.3649.3679.8461.6738.6982.45
24,17525,43524,52522,33820,54920,680
Revenue Growth (YoY)
-5.40%3.71%9.79%8.71%-0.63%-5.17%
Cost of Revenue
13,24014,12313,30212,63211,77712,009
Gross Profit
10,93611,31211,2239,7068,7728,671
Selling, General & Admin
6,2296,5636,1685,8275,3275,084
Research & Development
1,4281,4711,462966.86810.47767.55
Other Operating Expenses
188.65140.36202.61205.86224.56143.78
Operating Expenses
7,9668,2997,9047,0576,4116,015
Operating Income
2,9703,0143,3192,6492,3612,656
Interest Expense
-295.94-351.37-354.14-476.57-602.15-833.6
Interest & Investment Income
141.34185.18265.56978.8365.38376.23
Currency Exchange Gain (Loss)
-23.2-23.245.96123.67-58.34-100.37
Other Non Operating Income (Expenses)
-105.28-186.88-130.81120.33-59.2-169.14
EBT Excluding Unusual Items
2,6872,6373,1463,3952,0071,929
Impairment of Goodwill
-206.98-206.98-26.15-35.33-42.68-49.94
Gain (Loss) on Sale of Investments
54.350.08136.8543.427.8916.4
Gain (Loss) on Sale of Assets
-13.69-16.29-4.14-51.5126.06-3.35
Asset Writedown
-118.15-104.2-24.72-36.4-7.17-4.72
Other Unusual Items
62.9162.91156.13110.86182.16139.58
Pretax Income
2,4662,4233,3843,4262,1732,027
Income Tax Expense
611.42644.49568.56354.75354.78385.14
Earnings From Continuing Operations
1,8541,7782,8153,0711,8181,642
Minority Interest in Earnings
-425.46-448.6-680.78-587.19-501.05-636.46
Net Income
1,4291,3302,1342,4841,3171,006
Net Income to Common
1,4291,3302,1342,4841,3171,006
Net Income Growth
-26.94%-37.70%-14.07%88.60%30.96%19.37%
Shares Outstanding (Basic)
1,6351,6221,6171,6131,5871,378
Shares Outstanding (Diluted)
1,6351,6221,6291,6131,6061,378
Shares Change (YoY)
-0.42%-0.47%1.01%0.42%16.59%-5.16%
EPS (Basic)
0.870.821.321.540.830.73
EPS (Diluted)
0.870.821.311.540.820.73
EPS Growth
-26.63%-37.41%-14.94%87.81%12.33%25.86%
Free Cash Flow
1,4651,1438.93-672.27475.78991.85
Free Cash Flow Per Share
0.900.700.01-0.420.300.72
Dividend Per Share
0.3200.4700.4600.1600.1500.100
Dividend Growth
-47.54%2.17%187.50%6.67%50.00%100.00%
Gross Margin
45.23%44.47%45.76%43.45%42.69%41.93%
Operating Margin
12.29%11.85%13.53%11.86%11.49%12.84%
Profit Margin
5.91%5.23%8.70%11.12%6.41%4.86%
Free Cash Flow Margin
6.06%4.50%0.04%-3.01%2.31%4.80%
EBITDA
3,8873,8764,1083,3723,0203,337
EBITDA Margin
16.08%15.24%16.75%15.10%14.70%16.14%
D&A For EBITDA
917.26862.19788.75723.08659.23680.67
EBIT
2,9703,0143,3192,6492,3612,656
EBIT Margin
12.29%11.85%13.53%11.86%11.49%12.84%
Effective Tax Rate
24.80%26.60%16.80%10.35%16.33%19.00%
Revenue as Reported
24,17525,43524,52522,33820,54920,680
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.